Patients on anticoagulants/antiplatelets
Dental riskhigh
For most dental procedures, it is NOT necessary to stop anticoagulant or antiplatelet therapy — use local hemostatic measures and good planning instead. Stopping these drugs exposes patients to serious THROMBOEMBOLIC RISK. Core drugs: warfarin (VKA), DOACs (apixaban, rivarboxaban, dabigatran, edoxaban), aspirin, clopidogrel, DAPT combinations. SDCEP 2nd edition provides the primary dental management framework. Key principle: DO NOT advise interruption without the prescribing clinician's plan.
The full condition entry includes
- Safe vs avoid lists: antibiotics, analgesics, local anesthetics
- Vasoconstrictor limits and treatment modifications
- Pre/intra/post-op monitoring and deferral criteria
- Emergency management, explained for study
More medical conditions in dentistry
Hypertension (uncontrolled / hypertensive urgency)Ischemic heart disease (stable angina, recent/old MI)Heart failure (compensated vs decompensated)Valvular heart disease / Prosthetic heart valvesPatients on anticoagulants/antiplateletsCongenital heart disease (high-risk lesions/repairs)Pulmonary hypertensionCOPD (moderate-severe; oxygen dependence)Active upper respiratory infection (URI)Chronic hypoxemia / home oxygen patientsInterstitial lung disease / pulmonary fibrosisStroke / TIA history
Dentalverse is an educational resource for dental students and dentists. This page is a study reference — it is not medical advice and does not replace clinical judgment. Always follow your institution's protocols and your supervisor's guidance.